Cuicui Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cuicui Han has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Ming Bu
College of Pharmacy, Qiqihar Medical University, Qiqihar 161006, China
2 shared publications - Baiyu Jian
Graduate School of Heilongjiang University of Chinese Medicine, Heilongjiang University of Chinese Medicine, Harbin 150040, China
1 shared publication Denghui Li
College of Pharmacy, Qiqihar Medical University, Qiqihar, China
1 shared publication- Gang Chen
Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Bukui Road 333, Qiqihar 161006, China
1 shared publication - Haijun Wang
College of Pharmacy, Qiqihar Medical University, Qiqihar 161006, China
1 shared publication - Hao Zhang
Research Institute of Medicine and Pharmacy, Qiqihar Medical University, Qiqihar 161006, China
1 shared publication
Latest Publications
- 20 July 2026
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 96 (8) , 233
Design, Synthesis, and Antitumor Activity of Ergosterol Peroxide Hydrogen Sulfide Donor Derivatives
Hydrogen sulfide has been recognized as an effective endogenous signaling gasotransmitter, and exhibits antiproliferative activity against several cancer cells. To improve the antitumor activity of ergosterol peroxide (EP), a series of ergosterol peroxide hydrogen sulfide donor derivatives were synthesized by conjugating EP with an H2S-donating compound ADT-OH [5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione]. Most derivatives showed more potent antiproliferative activities than EP against A549 and HepG2 cell lines, while they were lack of sensitivity to MCF-7 cells. In particular, (3β,5α,8α,22E)-5,8-epidioxyergosta-6,22-dien-3-yl 5-[4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl] 3,3-dimethylpentanedioate showed the most potent antiproliferative activities against A549 cells with IC50 value of 2.52 μM, which demonstrated 7.4-fold improvement comparing to the parent compound EP. In the H2S release experiment, (3β,5α,8α,22E)-5,8-epidioxyergosta-6,22-dien-3-yl 5-[4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl] 3,3-dimethylpentanedioate was able to release a greater amount of H2S and reached its maximum value within 15 min. (3β,5α,8α,22E)-5,8-Epidioxyergosta-6,22-dien-3-yl 5-[4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl] 3,3-dimethylpentanedioate was also found have a strong binding affinity (–9.1 kcal/mol) with ATP-binding pocket of epidermal growth factor receptor (EGFR) protein. Additionally, the results of ADMET predictions suggested that these compounds possess favorable drug-like properties and good membrane permeability. The above findings indicate that this compound may become a highly promising lead compound for the development of anti-non-small cell lung cancer drugs.
- 20 July 2026
- Published by Pleiades Publishing Ltd in Russian Journal of General Chemistry
- Vol. 96 (8) , 233
Design, Synthesis, and Antitumor Activity of Ergosterol Peroxide Hydrogen Sulfide Donor Derivatives
Hydrogen sulfide has been recognized as an effective endogenous signaling gasotransmitter, and exhibits antiproliferative activity against several cancer cells. To improve the antitumor activity of ergosterol peroxide (EP), a series of ergosterol peroxide hydrogen sulfide donor derivatives were synthesized by conjugating EP with an H2S-donating compound ADT-OH [5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione]. Most derivatives showed more potent antiproliferative activities than EP against A549 and HepG2 cell lines, while they were lack of sensitivity to MCF-7 cells. In particular, (3β,5α,8α,22E)-5,8-epidioxyergosta-6,22-dien-3-yl 5-[4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl] 3,3-dimethylpentanedioate showed the most potent antiproliferative activities against A549 cells with IC50 value of 2.52 μM, which demonstrated 7.4-fold improvement comparing to the parent compound EP. In the H2S release experiment, (3β,5α,8α,22E)-5,8-epidioxyergosta-6,22-dien-3-yl 5-[4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl] 3,3-dimethylpentanedioate was able to release a greater amount of H2S and reached its maximum value within 15 min. (3β,5α,8α,22E)-5,8-Epidioxyergosta-6,22-dien-3-yl 5-[4-(3-thioxo-3H-1,2-dithiol-5-yl)phenyl] 3,3-dimethylpentanedioate was also found have a strong binding affinity (–9.1 kcal/mol) with ATP-binding pocket of epidermal growth factor receptor (EGFR) protein. Additionally, the results of ADMET predictions suggested that these compounds possess favorable drug-like properties and good membrane permeability. The above findings indicate that this compound may become a highly promising lead compound for the development of anti-non-small cell lung cancer drugs.
- Open Access
Discovery and Optimization of Ergosterol Peroxide Derivatives as Novel Glutaminase 1 Inhibitors for the Treatment of Triple-Negative Breast Cancer
In this study, novel ergosterol peroxide (EP) derivatives were synthesized and evaluated to assess their antiproliferative activity against four human cancer cell lines (A549, HepG2, MCF-7, and MDA-MB-231). Compound 3g exhibited the most potent antiproliferative activity, with an IC50 value of 3.20 µM against MDA-MB-231. This value was 5.4-fold higher than that of the parental EP. Bioassay optimization further identified 3g as a novel glutaminase 1 (GLS1) inhibitor (IC50 = 3.77 µM). In MDA-MB-231 cells, 3g reduced the cellular glutamate levels by blocking the glutamine hydrolysis pathway, which triggered reactive oxygen species production and induced caspase-dependent apoptosis. Molecular docking indicated that 3g interacts with the reaction site of the variable binding pocket by forming multiple interactions with GLS1. In a mouse model of breast cancer, 3g showed remarkable therapeutic effects at a dose of 50 mg/kg, with no apparent toxicity. Based on these results, 3g could be further evaluated as a novel GLS1 inhibitor for triple-negative breast cancer (TNBC) therapy.
Open AccessDiscovery and Optimization of Ergosterol Peroxide Derivatives as Novel Glutaminase 1 Inhibitors for the Treatment of Triple-Negative Breast Cancer
In this study, novel ergosterol peroxide (EP) derivatives were synthesized and evaluated to assess their antiproliferative activity against four human cancer cell lines (A549, HepG2, MCF-7, and MDA-MB-231). Compound 3g exhibited the most potent antiproliferative activity, with an IC50 value of 3.20 µM against MDA-MB-231. This value was 5.4-fold higher than that of the parental EP. Bioassay optimization further identified 3g as a novel glutaminase 1 (GLS1) inhibitor (IC50 = 3.77 µM). In MDA-MB-231 cells, 3g reduced the cellular glutamate levels by blocking the glutamine hydrolysis pathway, which triggered reactive oxygen species production and induced caspase-dependent apoptosis. Molecular docking indicated that 3g interacts with the reaction site of the variable binding pocket by forming multiple interactions with GLS1. In a mouse model of breast cancer, 3g showed remarkable therapeutic effects at a dose of 50 mg/kg, with no apparent toxicity. Based on these results, 3g could be further evaluated as a novel GLS1 inhibitor for triple-negative breast cancer (TNBC) therapy.
- Open Access
Chemical Composition, Anti-Breast Cancer Activity and Extraction Techniques of Ent-Abietane Diterpenoids from Euphorbia fischeriana Steud
Ent-abietane diterpenoids are the main active constituents of Euphorbia fischeriana. In the continuing search for new anti-breast cancer drugs, 11 ent-abietane diterpenoids (1–11) were isolated from E. fischeriana. The structures of these compounds were clearly elucidated on the basis of 1D and 2D NMR spectra as well as HRESIMS data. Among them, compound 1 was a novel compound, compound 10 was isolated from Euphorbia genus for the first time, compound 11 was firstly discovered from E. fischeriana. These compounds exhibited varying degrees of growth inhibition against the MCF-10A, MCF-7, ZR-75-1 and MDA-MB-231 cell lines in vitro. The experimental data obtained permit us to identify the roles of the epoxy group, hydroxyl group and acetoxyl group on their cytotoxic activities. Extraction is an important means for the isolation, identification, and application of valuable compounds from natural plants. To maximize yields of ent-abietane diterpenoids of E. fischeriana, 17-hydroxyjolkinolide B, jolkinolide B, 17-hydroxyjolkinolide A and jolkinolide A were selected as quality controls to optimize the salting-out-assisted liquid–liquid extraction (SALLE) by response surface methodology (RSM). The optimized conditions for SALLE were 0.47 g sodium dihydrogen phosphate, 5.5 mL acetonitrile and 4.5 mL water at pH 7.5. The experimental values of 17-hydroxyjolkinolide B, jolkinolide B, 17-hydroxyjolkinolide A and jolkinolide A (2.134, 0.529, 0.396, and 0.148 mg/g, respectively) were in agreement with the predicted values, thus demonstrating the appropriateness of the model.
Open AccessChemical Composition, Anti-Breast Cancer Activity and Extraction Techniques of Ent-Abietane Diterpenoids from Euphorbia fischeriana Steud
Ent-abietane diterpenoids are the main active constituents of Euphorbia fischeriana. In the continuing search for new anti-breast cancer drugs, 11 ent-abietane diterpenoids (1–11) were isolated from E. fischeriana. The structures of these compounds were clearly elucidated on the basis of 1D and 2D NMR spectra as well as HRESIMS data. Among them, compound 1 was a novel compound, compound 10 was isolated from Euphorbia genus for the first time, compound 11 was firstly discovered from E. fischeriana. These compounds exhibited varying degrees of growth inhibition against the MCF-10A, MCF-7, ZR-75-1 and MDA-MB-231 cell lines in vitro. The experimental data obtained permit us to identify the roles of the epoxy group, hydroxyl group and acetoxyl group on their cytotoxic activities. Extraction is an important means for the isolation, identification, and application of valuable compounds from natural plants. To maximize yields of ent-abietane diterpenoids of E. fischeriana, 17-hydroxyjolkinolide B, jolkinolide B, 17-hydroxyjolkinolide A and jolkinolide A were selected as quality controls to optimize the salting-out-assisted liquid–liquid extraction (SALLE) by response surface methodology (RSM). The optimized conditions for SALLE were 0.47 g sodium dihydrogen phosphate, 5.5 mL acetonitrile and 4.5 mL water at pH 7.5. The experimental values of 17-hydroxyjolkinolide B, jolkinolide B, 17-hydroxyjolkinolide A and jolkinolide A (2.134, 0.529, 0.396, and 0.148 mg/g, respectively) were in agreement with the predicted values, thus demonstrating the appropriateness of the model.
- Open Access
Anti-Cancer Activities of Diterpenoids Derived from Euphorbia fischeriana Steud
Euphorbia fischeriana Steud is an essential oriental folk medicine used for healing cancer, edema and tuberculosis. Recently, its anticancer activitity has attracted more attention. A volume of research has indicated that diterpenoids are the major anticancer active constituents from this medicinal herb. In this review, we aimed to provide a summary of the promising anticancer diterpenoids from this plant; many diterpenoids mentioned in this article are newly discovered diterpenoids. According to the carbon skeleton and substituents, they can be classified into eight subtypes: ent-abietane, daphnane, tigliane, ingenane, ent-atisane, ent-rosane, ent-kaurane, and lathyrane. Futhermore, their key anticancer mechanisms and protein targets of these compounds will be discussed. These natural diterpenoids could provide a reservoir for drug discovery.
Open AccessAnti-Cancer Activities of Diterpenoids Derived from Euphorbia fischeriana Steud
Euphorbia fischeriana Steud is an essential oriental folk medicine used for healing cancer, edema and tuberculosis. Recently, its anticancer activitity has attracted more attention. A volume of research has indicated that diterpenoids are the major anticancer active constituents from this medicinal herb. In this review, we aimed to provide a summary of the promising anticancer diterpenoids from this plant; many diterpenoids mentioned in this article are newly discovered diterpenoids. According to the carbon skeleton and substituents, they can be classified into eight subtypes: ent-abietane, daphnane, tigliane, ingenane, ent-atisane, ent-rosane, ent-kaurane, and lathyrane. Futhermore, their key anticancer mechanisms and protein targets of these compounds will be discussed. These natural diterpenoids could provide a reservoir for drug discovery.